David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medical Ethics 34 (2):63-64 (2008)
The discovery of an alternative method of producing induced human stem cells will affect the ethical evaluation of human embryonic stem cell researchOn 20 November 2007 two groups of researchers announced that they had independently managed to produce induced Pluripotent Cells from human adult somatic cells.1 2 The two groups used slightly different procedures, but both approaches involved overexpression of a group of four genes known to be actively expressed in human embryonic stem cells . The cells produced are very similar to human embryonic stem cells, they are pluripotent and they differentiate to specific cell types when treated according to protocols leading to that specific differentiation in hESC.WHAT ARE THE IMPLICATIONS OF THESE RESULTS FOR STEM CELL ETHICS?There seems to be at least two areas of debate and research where there are important implications and one area where there are none.Let us deal with the area where these results have absolutely no implications first: the contentious debate about the moral status of the embryo. Nothing in these research results will or can affect the position of those who believe that they have good arguments showing either that the embryo has no moral status at all, or that the embryo has such significant moral status that …
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Norman Ford (2011). Induced Pluripotent Stem Cells. Chisholm Health Ethics Bulletin 16 (4):4.
Zubin Master & G. K. D. Crozier (2012). The Ethics of Moral Compromise for Stem Cell Research Policy. Health Care Analysis 20 (1):50-65.
John F. Kilner (2009). An Inclusive Ethics for the Twenty-First Century: Implications for Stem Cell Research. Journal of Religious Ethics 37 (4):683-722.
Ronald K. F. Fung & Ian H. Kerridge (2013). Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (Ips) Cells. Bioethics 27 (2):89-96.
Norman Ford (2007). Stem Cells, Altered Nuclear Transfer & Ethics. Chisholm Health Ethics Bulletin 12 (3):9.
J. R. Meyer (2008). The Significance of Induced Pluripotent Stem Cells for Basic Research and Clinical Therapy. Journal of Medical Ethics 34 (12):849-851.
Melinda B. Fagan (2011). Social Experiments in Stem Cell Biology. Perspectives on Science 19 (3):235-262.
W. Malcolm Byrnes Edward J. Furton (2009). Comments on “Moral Complicity in Induced Pluripotent Stem Cell Research”. Kennedy Institute of Ethics Journal 19 (2):pp. 202-205.
W. Malcolm Byrnes & Edward J. Furton (2009). Comments on “Moral Complicity in Induced Pluripotent Stem Cell Research”. Kennedy Institute of Ethics Journal 19 (2):202-205.
Thomas V. Cunningham (2013). Skepticism About the “Convertibility” of Induced Pluripotent Stem Cells. American Journal of Bioethics 13 (1):40-42.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine & Ethics 38 (2):267-276.
Mariam Ghosn & Ford (2006). Stem Cell Technology Update. Chisholm Health Ethics Bulletin 12 (1):10.
Added to index2010-08-24
Total downloads5 ( #510,143 of 1,907,077 )
Recent downloads (6 months)1 ( #467,622 of 1,907,077 )
How can I increase my downloads?